prostate-report.org

Lowering Cholesterol May Stop Prostate Cancer Development and Progression

A recent study exploring the relationship between low-density lipoprotein (LDL) cholesterol and prostate- specific antigen (PSA) has found that low cholesterol levels may help reduce a person’s PSA level. This new study confirms that evidence and highlights the fact that cholesterol may play a role in prostate cancer development and progression.

Experts at the Durham Veteran Affairs Medical Center in North Carolina investigated data collected from men prescribed cholesterol-lowering drugs (statins) between 1990 and 2006. They concluded that PSA levels were reduced after starting statin medications and that this decline was proportional to the decline in LDL cholesterol.

The results of this study indicate that cholesterol and PSA are valuable indicators of overall health for men and should continue to be monitored together.

The study was presented at the 103rd Annual Scientific Meeting of the American Urological Association.

Tags: cholesterol, ldl, prostate specific antigen, psa